The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Selective Inhibition of Hypoxia-Inducible Factor 1α Ameliorates Adipose Tissue Dysfunction
Open accessAbstract
Hypoxia-inducible factor 1α (HIF1α) induction in adipocytes is a critical component of the "fibrotic response," directly linked to metabolic dysfunction in adipose tissues under hypoxic conditions. We reasoned that inhibition of HIF1α may ameliorate the negative aspects of the obesity-associated fat pad expansion. We used the selective HIF1α inhibitor PX-478, whose effectiveness has previously been established in tumor models. We demonstrate that PX-478 treatment effectively suppresses the high-fat-diet (HFD)-induced HIF1α activation in adipose tissue. HIF1α inhibition causes a reduction of weight gain in mice on an HFD but not on a chow diet. Treatment increases energy expenditure and prompts resistance to HFD-mediated deterioration of metabolic parameters. Moreover, PX-478-treated mice have reduced fibrosis and fewer inflammatory infiltrates in their adipose tissues. We confirm the metabolic effects obtained with PX-478 treatment using an adipose tissue-specific, doxycycline-inducible dominant negative HIF1α mutant (dn-HIF1α). Consistent with the pharmacological results, genetic inhibition of endogenous HIF1α activity prompts similar metabolic improvements in HFD-fed mice. Collectively, our results demonstrate that HIF1α inhibition in the adipocyte leads to significant metabolic improvements, suggesting that selective HIF1α inhibition in adipose tissue may be an effective therapeutic avenue in the context of metabolic dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, either overexpression of a dominant-negative HIF-1α or pharmacologic inhibition of HIF-1α significantly reduced AT fibrosis and improved AT function in mice fed a HFD (85).”
From The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. (2017) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“The heterodimers bind to genomic hypoxia response elements (HREs) and transactivate a wide variety of genes, including genes whose protein products are involved in cell survival, glycolysis, erythropoiesis, and angiogenesis (18, 19).”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210
Adipose tissue remodeling and obesity
Sun, K., Kusminski, C. M., & Scherer, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45887 · Cited by 1,941
Self-citationSalceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation
Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M., et al. (2007) · Diabetes · doi:10.2337/db06-0911 · Cited by 1,257
Flagged first, then by citations
1 of the 66 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Belozerov VE, 2006, Curr. Opin. Investig. Drugs, 7, 1067
- Ryan HE, 2000, Cancer Res., 60, 4010
- Virtanen KA, 2002, J. Clin. Endocrinol. Metab., 87, 3902, 10.1210/jcem.87.8.8761 · DOI · Paper page
Cited by
Sorted by citations
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Adipose-tissue plasticity in health and disease
Sakers, A. P., Siqueira, M. K. D., Seale, P., & Villanueva, C. J. (2022) · Cell · doi:10.1016/j.cell.2021.12.016 · Cited by 1,124
Fibrosis and adipose tissue dysfunction.
Sun, K., Tordjman, J., Clément, K., & Scherer, P. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.016 · Cited by 960
Self-citationA single-cell atlas of human and mouse white adipose tissue
Emont, M. P., Jacobs, C., Essene, A. L., Pant, D., Tenen, D., Colleluori, G., Di Vincenzo, A., Jørgensen, A. M., Dashti, H., Stefek, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04518-2 · Cited by 840
Obesity and cancer—mechanisms underlying tumour progression and recurrence
Park, J., Morley, T. S., Kim, M. G., Clegg, D. J., & Scherer, P. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.94 · Cited by 813
Self-citationThe ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis.
Crewe, C., An, Y. A., & Scherer, P. E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88883 · Cited by 732
Self-citationTargeting adipose tissue in the treatment of obesity-associated diabetes
Kusminski, C. M., Bickel, P. E., & Scherer, P. E. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.75 · Cited by 678
Self-citationFuster, J. J., Ouchi, N., Gokce, N., & Walsh, K. X. (2016) · Circulation Research · doi:10.1161/circresaha.115.306885 · Cited by 691
Lee, Y. S., Kim, J.-W., Osborne, O., Oh, D. Y., Sasik, R., Schenk, S., Chen, A., Chung, H., Murphy, A., Watkins, S. M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.012 · Cited by 598
The cell biology of fat expansion
Rutkowski, J. M., Stern, J. H., & Scherer, P. E. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201409063 · Cited by 541
Self-citationHypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
Havis, E., & Duprez, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051664 · Cited by 520
Mahajan, R., Lau, D. H., Brooks, A. G., SHIPP, N. J., Manavis, J., Wood, J. P. M., Finnie, J. W., Samuel, C. S., Royce, S. G., Twomey, D. J., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.058 · Cited by 464
An Integrated View of Immunometabolism
Lee, Y. S., Wollam, J., & Olefsky, J. M. (2018) · Cell · doi:10.1016/j.cell.2017.12.025 · Cited by 452
Vascular rarefaction mediates whitening of brown fat in obesity
Shimizu, I., Aprahamian, T. R., Kikuchi, R., Shimizu, A., Papanicolaou, K. N., MacLauchlan, S., Maruyama, S., & Walsh, K. X. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71643 · Cited by 435
The role of hypoxia-inducible factors in metabolic diseases
Gonzalez, F. J., Xie, C., & Jiang, C. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0096-z · Cited by 416
Metabolic adaptation and maladaptation in adipose tissue
Chouchani, E. T., & Kajimura, S. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0021-8 · Cited by 405
Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction
Sun, K., Park, J., Gupta, O. T., Holland, W. L., Auerbach, P., Zhang, N., Goncalves Marangoni, R., Nicoloro, S. M., Czech, M. P., Varga, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms4485 · Cited by 364
Self-citationChronic tissue inflammation and metabolic diseasePreprint
Lee, Y. S., & Olefsky, J. M. (2021) · Genes & Development · doi:10.1101/gad.346312.120 · Cited by 356
Hypoxia-inducible factors and the regulation of lipid metabolism
Mylonis, I., Simos, G., & Paraskeva, E. (2019) · Cells · doi:10.3390/cells8030214 · Cited by 316
Cao, Y. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.008 · Cited by 332
Pathophysiological implications of hypoxia in human diseases
Chen, P.-S., Chiu, W.-T., Hsu, P.-L., Lin, S.-C., Peng, I.-C., Wang, C.-Y., & Tsai, S.-J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00658-7 · Cited by 318
Deciphering the cellular interplays underlying obesity-induced adipose tissue fibrosis
Marcelin, G., Silveira, A. L. M., Martins, L. B., Ferreira, A. V. M., & Clément, K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129192 · Cited by 291
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
Zhao, Y., Xiong, W., Li, C., Zhao, R., Lu, H., Song, S., Zhou, Y., Hu, Y., Shi, B., & Ge, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01652-9 · Cited by 275
A PRDM16-Driven Metabolic Signal from Adipocytes Regulates Precursor Cell Fate
Wang, W., Ishibashi, J., Trefely, S., Shao, M., Cowan, A. J., Sakers, A. P., Lim, H., O’Connor, S., Doan, M. T., Cohen, P., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.005 · Cited by 223
Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification
Agarwal, S., Loder, S. J., Brownley, C., Cholok, D. J., Mangiavini, L., Li, J., Breuler, C. J., Hsieh, H. H. S., Li, S., Ranganathan, K., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515397113 · Cited by 227
Adipose tissue angiogenesis: Impact on obesity and type-2 diabetes
Corvera, S., & Gealekman, O. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.06.003 · Cited by 222
Cohen, P., & Spiegelman, B. M. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-10-0749 · Cited by 217
Adipose tissue and adipocyte dysregulation
Lafontan, M. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.08.002 · Cited by 218
Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis
Tanaka, M., Ikeda, K., Suganami, T., Komiya, C., Ochi, K., Shirakawa, I., Hamaguchi, M., Nishimura, S., Manabe, I., Matsuda, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms5982 · Cited by 206
Hypoxia and Adipocyte Physiology: Implications for Adipose Tissue Dysfunction in Obesity
Trayhurn, P. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161156 · Cited by 194
Adipose Tissue as an Endocrine Organ
McGown, C., Birerdinc, A., & Younossi, Z. M. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.012 · Cited by 200
Hasegawa, Y., Ikeda, K., Chen, Y., Alba, D., Stifler, D. R., Shinoda, K., Hosono, T., Maretich, P., Yang, Y., Ishigaki, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.005 · Cited by 182
Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications
Lau, D. H., Schotten, U., Mahajan, R., Antic, N. A., Hatem, S. N., Pathak, R. K., Hendriks, J., Kalman, J. M., & Sanders, P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv375 · Cited by 173
Hypoxia-inducible factors and diabetes
Gunton, J. E. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137556 · Cited by 159
Brown adipose tissue derived VEGF-A modulates cold tolerance and energy expenditure
Sun, K., Kusminski, C. M., Luby‐Phelps, K., Spurgin, S. B., An, Y., Wang, Q. A., Holland, W. L., & Scherer, P. E. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.03.010 · Cited by 152
Self-citationZhang, X., Zhang, Y., Wang, P., Zhang, S., Dong, Y., Zeng, G., Yan, Y., Sun, L., Wu, Q., Liu, H., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.016 · Cited by 154
The many secret lives of adipocytes: implications for diabetes
Scherer, P. E. (2018) · Diabetologia · doi:10.1007/s00125-018-4777-x · Cited by 164
Self-citationBuechler, C., Krautbauer, S., & Eisinger, K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i4.548 · Cited by 149
Decreased Adipose Tissue Oxygenation Associates with Insulin Resistance in Individuals with Obesity
Cifarelli, V., Beeman, S. C., Smith, G. I., Yoshino, J., Morozov, D., Beals, J. W., Kayser, B. D., Watrous, J. D., Jain, M., Patterson, B. W., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141828 · Cited by 132
Iftikhar, I. H., Hoyos, C. M., Phillips, C. L., & Magalang, U. J. (2015) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.4610 · Cited by 126
Self-citationRole of Cellular Senescence in Type II Diabetes
Narasimhan, A., Flores, R. R., Robbins, P. D., & Niedernhofer, L. J. (2021) · Endocrinology · doi:10.1210/endocr/bqab136 · Cited by 133
Nonalcoholic fatty liver disease and obstructive sleep apnea
Aron‐Wisnewsky, J., Clément, K., & Pépin, J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.004 · Cited by 129
Adipose Tissue Remodeling in Pathophysiology
Auger, C., & Kajimura, S. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042220-023633 · Cited by 135
Oxygen sensing and metabolic homeostasis
Palmer, B. F., & Clegg, D. J. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.08.001 · Cited by 120
Rahtu‐Korpela, L., Karsikas, S., Hörkkö, S., Sequeiros, R. T. B., Lammentausta, E., Mäkelä, K. A., Herzig, K., Walkinshaw, G., Kivirikko, K. I., Myllyharju, J., et al. (2014) · Diabetes · doi:10.2337/db14-0472 · Cited by 120
Knockdown of ANT2 reduces adipocyte hypoxia and improves insulin resistance in obesity
Seo, J. B., Riopel, M., Cabrales, P., Huh, J. Y., Bandyopadhyay, G. K., Andreyev, A. Y., Murphy, A. N., Beeman, S. C., Smith, G. I., Klein, S., et al. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0003-x · Cited by 111
Suzuki, T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15087 · Cited by 112
Adipose tissue changes in obesity and the impact on metabolic function
Sam, S., & Mazzone, T. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.008 · Cited by 113
Caputo, T., Gilardi, F., & Desvergne, B. (2017) · FEBS Letters · doi:10.1002/1873-3468.12742 · Cited by 112
Impact of obesity on cardiac metabolism, fibrosis, and function
Mahajan, R., Lau, D. H., & Sanders, P. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.09.005 · Cited by 109
The Implications of Obesity for Cardiac Arrhythmia Mechanisms and Management
Pathak, R. K., Mahajan, R., Lau, D. H., & Sanders, P. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.10.027 · Cited by 105
Warbrick, I., & Rabkin, S. W. (2019) · Obesity Reviews · doi:10.1111/obr.12828 · Cited by 100
Critical Role of Matrix Metalloproteinase 14 in Adipose Tissue Remodeling during Obesity
Li, X., Zhao, Y., Chen, C., Yang, L., Lee, H.-H., Wang, Z., Zhang, N., Kolonin, M. G., An, Z., Ge, X., et al. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00564-19 · Cited by 110
Self-citationType 2 diabetes – An autoinflammatory disease driven by metabolic stress
Gonzalez, L. L., Garrie, K., & Turner, M. D. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.034 · Cited by 101
An update on immune dysregulation in obesity‐related insulin resistance
Daryabor, G., Kabelitz, D., & Kalantar, K. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12747 · Cited by 99
Gaspar, J. M., & Velloso, L. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00813 · Cited by 97
Obesity-related kidney disease: Beyond hypertension and insulin-resistance
Arabi, T. Z., Shafqat, A., Sabbah, B. N., Ashraf, N., Shah, H., Abdulkader, H. S., Razak, A., Sabbah, A. N., & Arabi, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1095211 · Cited by 102
Pathologic HIF1α signaling drives adipose progenitor dysfunction in obesity
Shao, M., Hepler, C., Zhang, Q., Shan, B., Vishvanath, L., Henry, G. H., Zhao, S., An, Y., Wu, Y., Strand, D. W., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2020.12.008 · Cited by 87
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Cao, R. Y., Tian, H., Zhang, Y., Liu, G., Xu, H., Rao, G., Tian, Y., & Fu, X. (2023) · MedComm · doi:10.1002/mco2.283 · Cited by 98
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity
AlZaim, I., de Rooij, L. P. M. H., Sheikh, B. N., Börgeson, E., & Kalucka, J. M. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00893-6 · Cited by 95
Improved methodologies for the study of adipose biology: insights gained and opportunities ahead
Wang, Q. A., Scherer, P. E., & Gupta, R. K. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046441 · Cited by 88
Self-citationMicroglia activation in Niemann–Pick disease, type C1 is amendable to therapeutic intervention
Cougnoux, A., Drummond, R. A., Collar, A. L., Iben, J., Salman, A., Westgarth, H. J., Wassif, C. A., Cawley, N. X., Farhat, N. Y., Ozato, K., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy112 · Cited by 85
Partial leptin deficiency confers resistance to diet-induced obesity in mice
Zhao, S., Li, N., Zhu, Y., Straub, L. G., Zhang, Z., Wang, M.-Y., Zhu, Q., Kusminski, C. M., Elmquist, J. K., & Scherer, P. E. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.100995 · Cited by 83
Self-citationm6A methylation promotes white-to-beige fat transition by facilitating Hif1a translation
Wu, R., Chen, Y., Liu, Y., Zhuang, L., Chen, W., Zeng, B., Liao, X., Guo, G., Wang, Y., & Wang, X. (2021) · EMBO Reports · doi:10.15252/embr.202052348 · Cited by 82
Extracellular Matrix (ECM) and Fibrosis in Adipose Tissue: Overview and Perspectives
Sun, K., Li, X., & Scherer, P. E. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220020 · Cited by 162
Self-citationThe Adipocyte Acquires a Fibroblast-Like Transcriptional Signature in Response to a High Fat Diet
Jones, J. E. C., Rabhi, N., Orofino, J., Gamini, R., Perissi, V., Vernochet, C., & Farmer, S. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-59284-w · Cited by 79
Li, X., Li, J., Wang, L., Li, A., Qiu, Z., Qi, L., Kou, J., Liu, K., Liu, B., & Huang, F. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13493 · Cited by 76
Alolga, R. N., Nuer-Allornuvor, G. F., Kuugbee, E. D., Yin, X., & Ma, G. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104630 · Cited by 73
HIF-1α inhibitor PX-478 preserves pancreatic β cell function in diabetes
Ilegems, E., Bryzgalova, G., Correia, J. C., Yesildag, B., Berra, E., Ruas, J. L., Pereira, T., & Berggren, P. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.aba9112 · Cited by 72
Kim, J. Y., Lee, H. J., Lee, S., Jung, Y. H., Yoo, D. Y., Hwang, I. K., Seong, J. K., Ryu, J. M., & Han, H. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04175-w · Cited by 72
Balan, A. I., Halațiu, V.-B., & Scridon, A. (2024) · Antioxidants · doi:10.3390/antiox13010117 · Cited by 69
Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease
Lefere, S., Steenkiste, C. V., Verhelst, X., Vlierberghe, H. V., Devisscher, L., & Geerts, A. M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2222-1 · Cited by 70
The regulation of adipocyte growth in white adipose tissue
Li, Q., & Spalding, K. L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1003219 · Cited by 72
GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation
Drareni, K., Ballaire, R., Barilla, S., Mathew, M. J., Toubal, A., Fan, R., Liang, N., Chollet, C., Huang, Z., Kondili, M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.032 · Cited by 63
Wang, P., Zeng, G., Yan, Y., Zhang, S., Dong, Y., Zhang, Y., Zhang, X., Liu, H., Zhang, Z., Jiang, C., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.001 · Cited by 65
Adipocyte Pseudohypoxia Suppresses Lipolysis and Facilitates Benign Adipose Tissue Expansion
Michailidou, Z., Morton, N. M., Moreno‐Navarrete, J. M., West, C. C., Stewart, K. J., Fernández‐Real, J. M., Schofield, C. J., Seckl, J. R., & Ratcliffe, P. J. (2014) · Diabetes · doi:10.2337/db14-0233 · Cited by 59
Divergent functions of endotrophin on different cell populations in adipose tissue
Zhao, Y., Gu, X., Zhang, N., Kolonin, M. G., An, Z., & Sun, K. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2016 · Cited by 62
Self-citationSex-specific metabolic functions of adipose Lipocalin-2
Krishnan, K. C., Sabir, S., Shum, M., Meng, Y., Acín‐Pérez, R., Lang, J. M., Floyd, R. R., Vergnes, L., Seldin, M. M., Fuqua, B. K., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.009 · Cited by 59
Adipose HIF-1α causes obesity by suppressing brown adipose tissue thermogenesis
Jun, J. C., Devera, R., Unnikrishnan, D. C., Shin, M., Bevans‐Fonti, S., Yao, Q., Rathore, A., Younas, H., Halberg, N., Scherer, P. E., et al. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1480-6 · Cited by 58
Self-citationRegulation of glycolysis in brown adipocytes by HIF-1α
Basse, A. L., Isidor, M. S., Winther, S., Skjoldborg, N. B., Murholm, M., Andersen, E. S., Pedersen, S. B., Wolfrum, C., Quistorff, B., & Hansen, J. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-04246-y · Cited by 55
Mody, N., & Mcilroy, G. D. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.012 · Cited by 56
Jang, J. E., Ko, M. S., Yun, J.-Y., Kim, M., Kim, J. H., Park, H. S., Kim, A.-R., Kim, H.-J., Kim, B. J., Ahn, Y. E., et al. (2016) · Diabetes · doi:10.2337/db15-1624 · Cited by 59
Regulation of obesity and insulin resistance by hypoxia-inducible factors
Kim, J., Ban, J.-J., Ruthenborg, R. J., & Cho, K. (2014) · Hypoxia · doi:10.2147/hp.s68771 · Cited by 52
ERα upregulates Phd3 to ameliorate HIF-1 induced fibrosis and inflammation in adipose tissue
Kim, M., Neinast, M. D., Frank, A. P., Sun, K., Park, J., Zehr, J. A., Vishvanath, L., Morselli, E., Amelotte, M., Palmer, B. F., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.05.007 · Cited by 52
Self-citationYun, J.-W., Son, M.-J., Abdelmegeed, M. A., Banerjee, A., Morgan, T. R. M., Yoo, S.-H., & Song, B. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.030 · Cited by 50
Ballestri, S., Nascimbeni, F., Romagnoli, D., Baldelli, E., Targher, G., & Lonardo, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030355 · Cited by 48
Lin, Q., & Yun, Z. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00039 · Cited by 47
Zhao, Y., Li, X., Yang, L., Eckel‐Mahan, K. L., Tong, Q., Gu, X., Kolonin, M. G., & Sun, K. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00242-18 · Cited by 45
Self-citationLysyl oxidase and adipose tissue dysfunction
Pastel, E., Price, E., Sjöholm, K., McCulloch, L. J., Rittig, N. F., Liversedge, N., Knight, B., Møller, N., Svensson, P., & Kos, K. (2017) · Metabolism · doi:10.1016/j.metabol.2017.10.002 · Cited by 47
Adegunsoye, A., & Balachandran, J. S. (2015) · Mediators of Inflammation · doi:10.1155/2015/510105 · Cited by 45
Poblete, J. M. S., Ballinger, M. N., Bao, S., Alghothani, M., Nevado, J. B., Eubank, T. D., Christman, J. W., & Magalang, U. J. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00174.2019 · Cited by 44
Self-citationThe VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
Song, P., Zhang, J., Tan, X., Huang, Y., Xu, J., Silk, N., Zhang, D., Liu, Q., & Jiang, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.586857 · Cited by 42
Mechanistic Insights into the Link between Obesity and Prostate Cancer
Adesunloye, B. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083935 · Cited by 50
Obesity‐induced tissue alterations resist weight loss: A mechanistic review
Guardia, L. D., & Shin, A. C. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15637 · Cited by 45
Enhancing adipose tissue plasticity: progenitor cell roles in metabolic health
Lecoutre, S., Rebière, C., Maqdasy, S., Lambert, M., Dussaud, S., Abatan, J. B., Dugail, I., Gautier, E. L., Clément, K., & Marcelin, G. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01071-y · Cited by 52
Immune Cells Gate White Adipose Tissue Expansion
Cox, A. R., Chernis, N., Masschelin, P. M., & Hartig, S. M. (2019) · Endocrinology · doi:10.1210/en.2019-00266 · Cited by 39
Pescador, N., Francisco, V., Vázquez, P., Esquinas-Román, E. M., González-Paramos, C., Valdecantos, M. P., García‐Martinez, I., Urrutia, A. A., Ruíz-Cañas, L., Escalona-Garrido, C., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102171 · Cited by 39
Hypoxia inducible factor 1α inhibitor PX-478 reduces atherosclerosis in mice
Villa-Roel, N., Ryu, K., Gu, L., Esmerats, J. F., Kang, D. W., Kumar, S., & Jo, H. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.01.002 · Cited by 39
The role of hypoxia-inducible factor 1α in hepatic lipid metabolism
Luo, M., Li, T., & Sang, H. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02308-5 · Cited by 42
Metadata
- Authors
- Sun, K., Halberg, N., Khan, M., Magalang, U. J., & Scherer, P. E.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- The Ohio State University (US)
- The Ohio State University Wexner Medical Center (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2013-03-01
- Volume
- 33
- Issue
- 5
- Pages
- 904-917
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3623075
- OpenAlex
- W2155306967
- Cited by
- 231
- References
- 66
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 15 · 2023: 25 · 2022: 22 · 2021: 15 · 2020: 21 · 2019: 15 · 2018: 21 · 2017: 11 · 2016: 19 · 2015: 14 · 2014: 24 · 2013: 7
- FWCI
- 10.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ohio State University
- University of Texas Southwestern Medical Center
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL-093463, R01HL093463)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK 55758, R01DK055758, RC1DK086629, P01DK088761)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- hypoxia-inducible factor-1α, PX-478, adipose tissue dysfunction, obesity, high-fat diet, adipose tissue fibrosis, energy expenditure, adipose tissue inflammation, metabolic dysfunction
- MeSH terms
- Adipose Tissue, Animals, Digoxin, Energy Metabolism, Fatty Liver, Glucose Tolerance Test, Liver, Male, Mice, Inbred C57BL, Mice, Transgenic, Mustard Compounds, Mutation, Oxygen, Phenylpropionates, Weight Gain, Up-Regulation, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
